Literature DB >> 11532000

Mutational analysis of the J recombination signal sequence binding protein (RBP-J)/Epstein-Barr virus nuclear antigen 2 (EBNA2) and RBP-J/Notch interaction.

K P Fuchs1, G Bommer, E Dumont, B Christoph, M Vidal, E Kremmer, B Kempkes.   

Abstract

Epstein-Barr virus nuclear antigen 2 (EBNA2) and the Notch protein both function within the nucleus as transcriptional adaptor proteins. EBNA2 plays a key role during the immortalization of primary B-cells by Epstein-Barr virus (EBV). Notch proteins are involved in lymphomagenesis as well as in multiple cell fate decisions during tissue differentiation and development. Both, EBNA2 and Notch interact with the DNA binding protein RBP-J and thereby gain access to the promoter of their target genes. In order to identify regions within the J recombination signal sequence binding protein (RBP-J), that are relevant for either the Notch or the EBNA2 interaction, we have performed a mutational analysis of RBP-J. A library of RBP-J mutants was screened by a reverse two-hybrid system for alleles that fail to bind to either EBNA2 or Notch. The sequence analysis of these alleles reveals that a limited and particularly distinct number of amino-acid positions are relevant for either interaction only. Given the important role of RBP-J in B-cell immortalization, the EBNA2/RBP-J protein-protein interaction could be a candidate target for therapeutic intervention in EBV related diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532000     DOI: 10.1046/j.1432-1327.2001.02387.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Crystal structure of the nuclear effector of Notch signaling, CSL, bound to DNA.

Authors:  Rhett A Kovall; Wayne A Hendrickson
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

2.  Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4/K10) is a novel interaction partner of CSL/CBF1, the major downstream effector of Notch signaling.

Authors:  Katharina Heinzelmann; Barbara A Scholz; Agnes Nowak; Even Fossum; Elisabeth Kremmer; Juergen Haas; Ronald Frank; Bettina Kempkes
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

3.  Thermodynamic analysis of the CSL x Notch interaction: distribution of binding energy of the Notch RAM region to the CSL beta-trefoil domain and the mode of competition with the viral transactivator EBNA2.

Authors:  Scott E Johnson; M Xenia G Ilagan; Raphael Kopan; Doug Barrick
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

4.  Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.

Authors:  Michael A Calderwood; Sungwook Lee; Amy M Holthaus; Stephen C Blacklow; Elliott Kieff; Eric Johannsen
Journal:  Virology       Date:  2011-03-26       Impact factor: 3.616

5.  Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide.

Authors:  Christopher J Farrell; Jae Myun Lee; Eui-Cheol Shin; Marek Cebrat; Philip A Cole; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

6.  Structure and function of the CSL-KyoT2 corepressor complex: a negative regulator of Notch signaling.

Authors:  Kelly J Collins; Zhenyu Yuan; Rhett A Kovall
Journal:  Structure       Date:  2013-11-27       Impact factor: 5.006

7.  Dissecting and circumventing the requirement for RAM in CSL-dependent Notch signaling.

Authors:  Scott E Johnson; Douglas Barrick
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

8.  Structural and functional analysis of the repressor complex in the Notch signaling pathway of Drosophila melanogaster.

Authors:  Dieter Maier; Patricia Kurth; Adriana Schulz; Andrew Russell; Zhenyu Yuan; Kim Gruber; Rhett A Kovall; Anette Preiss
Journal:  Mol Biol Cell       Date:  2011-07-07       Impact factor: 4.138

9.  Dishevelled limits Notch signalling through inhibition of CSL.

Authors:  Giovanna M Collu; Ana Hidalgo-Sastre; Ahmet Acar; Laura Bayston; Clara Gildea; Michael K Leverentz; Christopher G Mills; Thomas W Owens; Olivier Meurette; Karel Dorey; Keith Brennan
Journal:  Development       Date:  2012-12-01       Impact factor: 6.868

10.  Fungal CSL transcription factors.

Authors:  Martin Prevorovský; Frantisek Půta; Petr Folk
Journal:  BMC Genomics       Date:  2007-07-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.